about
New perspectives in occult hepatitis C virus infectionQuantity and Quality of Inhaled Dose Predicts Immunopathology in TuberculosisChronic hepatitis C and liver fibrosis.Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.Production and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infectionHCV infection should be managed in specialist centresMultispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearanceMonitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen AssayAnalysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated ControlsHigh levels of subgenomic HCV plasma RNA in immunosilent infectionsCoordinated evolution of the hepatitis C virusIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesComparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast BrazilThe Hepatitis C Virus NS4B Protein Can trans-Complement Viral RNA Replication and Modulates Production of Infectious VirusAssociation between hepatitis C and hepatocellular carcinomaHepatitis C virus: Virology, diagnosis and treatmentHepatitis C screeningThe new era of hepatitis C virus therapyDistinct plasma immune signatures in ME/CFS are present early in the course of illnessHepatitis C virus antigenic convergenceThe impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Prospective study in 142 cases of hepatitis C virus infectionTreatment of hepatitis C. The 2002 French consensus.Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C.Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patientsHepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugsHepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.Production and pathogenicity of hepatitis C virus core gene products.Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action.Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.Impact of hepatitis C virus infection on lifestyle.Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and BoceprevirManagement of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infectionTherapy of acute hepatitis C.Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C
P2860
Q22305491-2AA51D7E-E0A9-429D-96BF-250C8EFDC70EQ26801645-5A3F7B4E-6366-4E4E-96D6-64EFD69F5B86Q26825671-61E7253C-0EDE-4DA4-9BCB-A938912FC615Q27469682-D04883A5-C37E-4C2A-8324-619140AF823AQ27470002-D3D25D7F-5115-4715-891B-B528DBF4DABAQ27477855-0961463C-FE72-4687-A0F0-F592EB73EA17Q27477960-431184CA-FC59-4C06-A4D4-03DA9237627AQ27477974-039BFB93-F009-40CF-AB06-FFF92DFB663CQ27478083-5E245952-6993-4CED-9E75-BBBCD7614A86Q27480341-2EA68C6E-2DB1-44CE-97AB-7A6DD2568942Q27481224-108E318E-12FA-44A8-AB56-A702AE962C22Q27486431-71AF1A4D-01B8-4364-8484-534635CE3666Q27487399-D342E797-CB27-4C26-902D-E68F975D83F3Q27487535-B396816E-3C69-4F74-893D-5A9CD8D8AE8DQ27487943-D7997060-FB62-4BBF-A8CF-251038458AC3Q27491295-DD6AFD3A-9DFC-40F7-A86E-80B0085CF3B7Q28082000-8C3EF93E-0BE3-483E-805F-7D64763C557AQ28083429-BB71EAC1-52D5-4853-BD47-E56583024273Q28086947-C7B3C789-7831-4557-B2F6-786532B67B4EQ28263550-2A1AA74E-0785-496A-B10B-15DC0DE42976Q28732097-8853BCFD-5DE8-4440-9D5C-F8C5071602D1Q30250096-A4ED4C4B-215D-406B-A6F4-C6D05EAAAB37Q30837893-040DCFB7-50F2-4BA6-AA60-C39EA4D57068Q33195269-F4DC10E0-44D4-440D-91B4-AC31D99B9F90Q33338255-AA2CE160-7CEE-4D79-A9D1-A034ACE352DFQ33362712-5ADD4E01-86A6-4CE8-846E-245F66E6DC16Q33618436-A37AEE46-DAA0-47E3-A598-CF49316EF49DQ33735206-E239AE7A-3C67-4287-9C19-E48A1517A6FAQ33780095-FE66A50F-93B3-4909-A287-0F43A8BEEA87Q33790966-837594DF-073A-4D6D-8BF3-4C77E724B8E5Q33866383-59242FD0-02DB-46BA-86BE-5E7AA067E3B2Q33878202-CBF0B78C-587B-4AB9-AFA9-984C80E7ABDFQ34099523-38B220AA-8932-4F07-9262-F9B89160E72BQ34100056-2A49E0E6-BA88-4787-A171-D026E979CA16Q34399105-244DBC22-57FC-4333-8132-A2BB020706FAQ34614976-A54B8D86-99D2-4601-A584-E5540BAC012AQ34638892-AF68E02E-2D1E-46E8-BC11-5F699D10717DQ34923937-AFEDB8FF-6343-41AB-AC2E-9CE475202877Q34984119-4F7FC505-39C4-4CDE-B5A8-7EE7BE6FA748Q34991008-7479A530-8323-4ECF-947D-1235F5E19F97
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Natural history of hepatitis C.
@ast
Natural history of hepatitis C.
@en
type
label
Natural history of hepatitis C.
@ast
Natural history of hepatitis C.
@en
prefLabel
Natural history of hepatitis C.
@ast
Natural history of hepatitis C.
@en
P2093
P1476
Natural history of hepatitis C.
@en
P2093
P356
10.1016/S0168-8278(99)80369-9
P478
31 Suppl 1
P577
1999-01-01T00:00:00Z